Market growth is fueled by increasing prevalence of chronic neurological conditions, rising demand for targeted pain management, and innovations in implantable and wearable neurostimulation ...

The FDA has approved the first prescription, at-home neuromodulation therapy for individuals with major depressive disorder ...

More than a billion people worldwide struggle to find relief from the unbearable pain of migraine. But research is leading to ...

ReShape Lifesciences has received a Notice of Allowance from the U.S. Patent and Trademark Office for its patent application on a new Diabetes Neuromodulation system utilizing its vagal nerve block ...

ImagineHealth and Vivatronix partner to bring SpineX’s neuromodulation technology to global markets, enhancing recovery for neurological condition patients. Patients have been waiting for a solution ...

CVRx’s stock has risen nearly 20% after the company revealed that its heart failure device is set to be investigated in an ...

The wearable device delivers electrical impulses through a headset that can be administered by the patient at home under ...

PLANO, Texas, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), one of the largest medical device contract development and manufacturing organizations (CDMO) in the world, ...

PLANO, Texas, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), one of the largest medical device contract development and manufacturing organizations (CDMO) in the world, ...

Given the growing interest in non-invasive neuromodulation devices for the central nervous system, the Forum on Neuroscience and Nervous System Disorders hosted a public workshop on March 2-3, 2015 to ...